Certificate marks on outer pakage to be granted.

The KFDA may allow for the duplicate drug proven of its bio-equivalency to the original one to show a certificate mark in letter or design on the outer packages in order to endorse its product credibility and to boost more substituted dispensing.

This plan will be reflected to the working rules of the Pharmaceutical Affairs Act after full discussion with the KPMA, enforcing it from the next ...